STAA
Price
$17.87
Change
+$0.47 (+2.70%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
1.91B
60 days until earnings call
WST
Price
$224.69
Change
+$6.11 (+2.80%)
Updated
Jun 6 closing price
Capitalization
28.97B
47 days until earnings call
Interact to see
Advertisement

STAA vs WST

Header iconSTAA vs WST Comparison
Open Charts STAA vs WSTBanner chart's image
STAAR Surgical
Price$17.87
Change+$0.47 (+2.70%)
Volume$14.28K
Capitalization1.91B
West Pharmaceutical Services
Price$224.69
Change+$6.11 (+2.80%)
Volume$976.06K
Capitalization28.97B
STAA vs WST Comparison Chart
Loading...
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STAA vs. WST commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STAA is a StrongBuy and WST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (STAA: $17.87 vs. WST: $224.69)
Brand notoriety: STAA and WST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: STAA: 99% vs. WST: 117%
Market capitalization -- STAA: $1.91B vs. WST: $28.97B
STAA [@Medical Specialties] is valued at $1.91B. WST’s [@Medical Specialties] market capitalization is $28.97B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.52B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STAA’s FA Score shows that 0 FA rating(s) are green whileWST’s FA Score has 0 green FA rating(s).

  • STAA’s FA Score: 0 green, 5 red.
  • WST’s FA Score: 0 green, 5 red.
According to our system of comparison, WST is a better buy in the long-term than STAA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STAA’s TA Score shows that 5 TA indicator(s) are bullish while WST’s TA Score has 5 bullish TA indicator(s).

  • STAA’s TA Score: 5 bullish, 5 bearish.
  • WST’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, WST is a better buy in the short-term than STAA.

Price Growth

STAA (@Medical Specialties) experienced а +0.34% price change this week, while WST (@Medical Specialties) price change was +6.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.46%. For the same industry, the average monthly price growth was +5.98%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

STAA is expected to report earnings on Aug 06, 2025.

WST is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+2.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WST($29B) has a higher market cap than STAA($1.91B). STAA has higher P/E ratio than WST: STAA (90.79) vs WST (50.25). STAA YTD gains are higher at: -26.431 vs. WST (-31.294). WST has higher annual earnings (EBITDA): 844M vs. STAA (33.2M). WST has more cash in the bank: 854M vs. STAA (221M). STAA has less debt than WST: STAA (35.8M) vs WST (309M). WST has higher revenues than STAA: WST (2.95B) vs STAA (322M).
STAAWSTSTAA / WST
Capitalization1.91B29B7%
EBITDA33.2M844M4%
Gain YTD-26.431-31.29484%
P/E Ratio90.7950.25181%
Revenue322M2.95B11%
Total Cash221M854M26%
Total Debt35.8M309M12%
FUNDAMENTALS RATINGS
STAA vs WST: Fundamental Ratings
STAA
WST
OUTLOOK RATING
1..100
7719
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
9249
PRICE GROWTH RATING
1..100
8762
P/E GROWTH RATING
1..100
8871
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WST's Valuation (77) in the Medical Specialties industry is in the same range as STAA (82). This means that WST’s stock grew similarly to STAA’s over the last 12 months.

WST's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as STAA (100). This means that WST’s stock grew similarly to STAA’s over the last 12 months.

WST's SMR Rating (49) in the Medical Specialties industry is somewhat better than the same rating for STAA (92). This means that WST’s stock grew somewhat faster than STAA’s over the last 12 months.

WST's Price Growth Rating (62) in the Medical Specialties industry is in the same range as STAA (87). This means that WST’s stock grew similarly to STAA’s over the last 12 months.

WST's P/E Growth Rating (71) in the Medical Specialties industry is in the same range as STAA (88). This means that WST’s stock grew similarly to STAA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STAAWST
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 19 days ago
75%
Bullish Trend 1 day ago
68%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 16 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
STAA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JUESX24.90N/A
N/A
JPMorgan US Equity I
PJSQX22.98N/A
N/A
PGIM Jennison Small Company R6
EPGFX13.78N/A
N/A
EuroPac Gold A
HFDFX18.84N/A
N/A
Hartford Schroders US MidCap Opps F
MCTOX11.56N/A
N/A
Modern Capital Tactical Income A